Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000518062 | SCV000612939 | uncertain significance | not specified | 2016-12-31 | criteria provided, single submitter | clinical testing | |
Neuberg Centre For Genomic Medicine, |
RCV003338627 | SCV004047816 | uncertain significance | Autosomal dominant Alport syndrome | criteria provided, single submitter | clinical testing | The missense c.1127C>T (p.Pro376Leu) variant in COL4A3 gene has been submitted to ClinVar as a Variant of Uncertain Significance, but no details are available for independent assessment. It has not been reported in affected individuals. The variant is observed in 0.002% alleles in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The amino acid Pro at position 376 is changed to a Leu changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Pro376Leu in COL4A3 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain significance. | |
Fulgent Genetics, |
RCV005018875 | SCV005648955 | uncertain significance | Autosomal dominant Alport syndrome; Hematuria, benign familial, 2; Alport syndrome 3b, autosomal recessive | 2024-03-20 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834657 | SCV002076389 | uncertain significance | Alport syndrome | 2019-10-28 | no assertion criteria provided | clinical testing |